Puma Biotech gets EU panel nod for breast cancer drug
June 29, 2018 at 07:51 AM EDT
June 29 (Reuters) - Puma Biotechnology Inc on Friday won a key recommendation from a European Medicines Agency panel on its lead breast cancer drug, five months after the regulator recommended against approving it.
